A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Gumusay O, Huppert LA, Magbanua MJM, Wabl CA, et al. Breast Cancer Res Treat 2023 Oct 10. doi: 10.1007/s10549-023-07073.

Read + Share

Amedeo Smart

Independent Medical Education

Gumusay O, Huppert LA, Magbanua MJM, Wabl CA, et al. A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Breast Cancer Res Treat 2023 Oct 10. doi: 10.1007/s10549-023-07073.
PMID: 37815684